±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 606  |  »Ø¸´: 11
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

000zgh000

гæ (СÓÐÃûÆø)

[½»Á÷] °ïæ¿´Ò»ÏÂÕ⼸¸ö¾ä×ÓÓÐûÓÐÎÊÌâ

1. Like other malignant diseases, polygenes involvement coupled with accumulation of genetic and epigenetic changes make the high mortality rate without markedly changed.
2.  HCC often coupled with liver dysfunction restrict the use of conventional chemotherapeutics as there are more or less non-selective toxicity with significant systemic side effects.
Çë´óÏÀÃǰﰳ¿´¿´ÕâÁ½¸ö¾ä×ÓÓÐÎÊÌâÂð£¬Èç¹ûÓУ¬ÔõôÐ޸İ¡£¬¼±¼±¼±¡­¡­·Ç³£¸Ðл¹þ¡­¡­£¡£¡£¡

» ²ÂÄãϲ»¶

ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yuyang031985

½ð³æ (ÕýʽдÊÖ)

¡ï ¡ï
000zgh000(½ð±Ò+1,VIP+0): 9-14 09:03
linghanyuan(½ð±Ò+1,VIP+0):лл½»Á÷ 9-14 14:06
1. Like other malignant diseases, polygenes involvement coupled with the accumulation of genetic and epigenetic changes result in the high mortality rate, which was not changed significantly.
2.  HCC often coupled with liver dysfunction restricts the use of conventional chemotherapeutics, for there is more or less non-selective toxicity of systemic side effects.

¿´¿´°É£¬×öÁ˲¿·Öµ÷Õû
˵˵Äã²»¿ªÐĵÄÊÂÈÃÎÒÃÇ¿ªÐÄһϹþ£¡
2Â¥2009-09-14 08:57:39
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wangwei2008

ľ³æ (Ö°Òµ×÷¼Ò)

Сľ³æÖ®ÒÆ»¨¹¬Ö÷

Â¥ÉϵÄͦºÃ
3Â¥2009-09-14 09:03:36
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nono2009

³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)

No gains, no pains.

ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐã°æÖ÷

¡ï
linghanyuan(½ð±Ò+1,VIP+0):лл½»Á÷ 9-14 20:21
Following the 2nd floor:

1. Like other malignant diseases, polygenes involvement coupled with the accumulation of genetic and epigenetic changes results in the high mortality rate, which was not changed significantly.

(result in => results in?)
4Â¥2009-09-14 20:01:18
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

goodtimega

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡ï
linghanyuan(½ð±Ò+1,VIP+0):лл½»Á÷ 9-14 20:22
1. Similar to other malignant diseases, the involvement of  polygenes coupled with the accumulation of genetic and epigenetic changes yields high mortality rate without significant change.
2.  HCC coupled with liver dysfunction restricts the use of conventional chemotherapeutics, for there is more or less non-selective toxicity of systemic side effects.
5Â¥2009-09-14 20:06:37
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

seebrightplan

ľ³æ (ÖøÃûдÊÖ)

Solider

¡ï
linghanyuan(½ð±Ò+1,VIP+0):¹ÄÀø½»Á÷ 9-25 15:28
1. Like other malignant diseases, the involvement of the polygenes involvement coupled with the accumulation of genetic and epigenetic changes results in high mortality rate with neglected changing.
2.  HCC often coupled with liver dysfunction restricts the use of the conventional chemotherapeutics since there ismore or less non-selective toxicity with significant systemic side effects.
Ö»´ËÒ»ÉúĪÌý´©ÁÖ´òÒ¶Éù£¬ºÎ·ÁÒ÷Ð¥ÇÒÐìÐС£ÖñÕÈâЬÇáʤÂí£¬Ë­Å£¿Ò»ËòÑÌÓêÈÎÆ½Éú¡£ÁÏÇÍ´º·ç´µ¾ÆÐÑ£¬Î¢À䣬ɽͷбÕÕÈ´ÏàÓ­¡£»ØÊ×ÏòÀ´Ïôɪ´¦£¬¹éÈ¥£¬Ò²ÎÞ·çÓêÒ².
6Â¥2009-09-15 12:52:23
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

abstqq123

гæ (СÓÐÃûÆø)

¡ï
linghanyuan(½ð±Ò+1,VIP+0):¹ÄÀøÐ³æ 9-25 15:27
Following the 2nd floor:

1. Like other malignant diseases, polygenes involvement coupled with the accumulation of genetic and epigenetic changes results in the high mortality rate, which was not changed significantly.

(result in => results in?)
7Â¥2009-09-18 13:56:49
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jw227

ľ³æ (ÖøÃûдÊÖ)

¿ÎÌâ×鳤

¡ï
linghanyuan(½ð±Ò+1,VIP+0):лл½»Á÷ 9-25 15:27
Like other malignant diseases, polygenes involvement coupled with  genetic and epigenetic accumulation changes led to the  high mortality rate unchanged

HCC together with liver dysfunction restricts the use of conventional chemotherapeutics since there are more or less non-selective toxicity in significant systemic side effects.
ÎÒÊÇÀ´ÏûDzµÄ
8Â¥2009-09-20 13:36:15
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

chaokai

½ð³æ (³õÈëÎÄ̳)

¡ï
linghanyuan(½ð±Ò+1,VIP+0):¹ÄÀøÐ³æ 9-25 15:28
moralityÒѾ­±íʾËÀÍöÂÊ ËùÒÔӦȥµôrate
9Â¥2009-09-24 12:09:30
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

·É×ßµÄÏ£Íû

ľ³æ (ÖøÃûдÊÖ)

ЦµÄÌ«³Õµß

дµÃ²»´í£¬Ð»Ð»Ö¸µ¼
10Â¥2009-10-03 14:12:33
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ 000zgh000 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 325Çóµ÷¼Á +4 ´º·ç²»½èÒâ 2026-04-04 4/200 2026-04-04 22:08 by à£à£à£0119
[¿¼ÑÐ] 070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á +8 Áº¸»¹óÏÕÖÐÇó 2026-04-04 10/500 2026-04-04 20:57 by imissbao
[¿¼ÑÐ] Ò»Ö¾Ô¸9²ÄÁÏѧ˶297ÒѹýÁù¼¶Çóµ÷¼ÁÍÆ¼ö +8 adaie 2026-04-04 9/450 2026-04-04 17:37 by oooqiao
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏÅ©090401£¬268£¬Çóµ÷¼Á +5 һľÄñÈ» 2026-04-04 5/250 2026-04-04 17:07 by babysonlkd
[¿¼ÑÐ] 343Çóµ÷¼Á +8 °®î¿°í 2026-03-29 8/400 2026-04-03 22:19 by –¹Æ?
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖØÇì´óѧ085404£¬×Ü·Ö314·Ö£¬Çóµ÷¼Á +4 zf83hn 2026-04-03 4/200 2026-04-03 21:25 by à£à£à£0119
[¿¼ÑÐ] Çóµ÷¼Á»ú»á +5 ÒâȾivy 2026-04-03 5/250 2026-04-03 15:13 by qoooooo614
[¿¼ÑÐ] Ò»Ö¾Ô¸ÉúÎïÓëÒ½Ò©£¬296·Ö£¬Çóµ÷¼Á +8 66¹ 2026-04-03 9/450 2026-04-03 14:22 by »¯Ñ§»¯¹¤Ë¶Ê¿ÕÐÉ
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +9 Ë«ÂíβƦÀϰå2 2026-04-01 9/450 2026-04-02 12:14 by oooqiao
[¿¼ÑÐ] 0856³õÊÔ324·ÖÇóµ÷¼Á +6 ÏëÉÏѧÇóµ÷ 2026-04-01 6/300 2026-04-02 11:42 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 0710ÉúÎïѧ£¬325Çóµ÷¼Á +3 mkkkkkl 2026-04-01 3/150 2026-04-02 09:48 by Jaylen.
[¿¼ÑÐ] 304Çóµ÷¼Á +12 ËØÄê¼ÀÓï 2026-03-31 15/750 2026-04-01 22:41 by peike
[¿¼ÑÐ] 085602»¯Ñ§¹¤³Ì268·Ö¶×µ÷¼Á +8 ÔÂÕÕ»¨ÁÖ¡£ 2026-04-01 8/400 2026-04-01 22:08 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 290Çóµ÷¼Á +5 dfffsar 2026-03-29 5/250 2026-04-01 19:45 by 6781022
[¿¼ÑÐ] 085600£¬320·ÖÇóµ÷¼Á +5 ´ó²öС×Ó 2026-04-01 6/300 2026-04-01 19:40 by ÌÆãå¶ù
[¿¼ÑÐ] Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +7 @taotao 2026-03-30 7/350 2026-04-01 14:30 by chenqifeng666
[¿¼ÑÐ] 070300»¯Ñ§×¨Òµ279µ÷¼Á +10 ¹þ¹þ¹þ^_^ 2026-03-31 10/500 2026-03-31 23:13 by liu823948201
[¿¼ÑÐ] Çóµ÷¼Á ÉúÎïѧ 377·Ö +6 zzll03 2026-03-31 6/300 2026-03-31 17:33 by ÌÆãå¶ù
[»ù½ðÉêÇë] ÃæÉÏ5BÄÜÉÏ»áÂ𣿠+8 redcom 2026-03-29 8/400 2026-03-31 15:53 by niuailing
[¿¼ÑÐ] 274Çóµ÷¼Á +6 xiao°®Í¬Ñ§ 2026-03-30 6/300 2026-03-31 10:04 by cal0306
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û